Literature DB >> 10024102

Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.

O Farges1, B Malassagne, J F Flejou, S Balzan, A Sauvanet, J Belghiti.   

Abstract

OBJECTIVE: To explore the relation of patient age, status of liver parenchyma, presence of markers of active hepatitis, and blood loss to subsequent death and complications in patients undergoing a similar major hepatectomy for the same disease using a standardized technique. SUMMARY BACKGROUND DATA: Major liver resection carries a high risk of postoperative liver failure in patients with chronic liver disease. However, this underlying liver disease may comprise a wide range of pathologic changes that have, in the past, not been well defined.
METHODS: The nontumorous liver of 55 patients undergoing a right hepatectomy for hepatocellular carcinoma was classified according to a semiquantitative grading of fibrosis. The authors analyzed the influence of this pathologic feature and of other preoperative variables on the risk of postoperative death and complications.
RESULTS: Serum bilirubin and prothrombin time increased on postoperative day 1, and their speed of recovery was influenced by the severity of fibrosis. Incidence of death from liver failure was 32% in patients with grade 4 fibrosis (cirrhosis) and 0% in patients with grade 0 to 3 fibrosis. The preoperative serum aspartate transaminase (ASAT) level ranged from 68 to 207 IU/l in patients with cirrhosis who died, compared with 20 to 62 in patients with cirrhosis who survived.
CONCLUSION: A major liver resection such as a right hepatectomy may be safely performed in patients with underlying liver disease, provided no additional risk factors are present. Patients with a preoperative increase in ASAT should undergo a liver biopsy to rule out the presence of grade 4 fibrosis, which should contraindicate this resection.

Entities:  

Mesh:

Year:  1999        PMID: 10024102      PMCID: PMC1191633          DOI: 10.1097/00000658-199902000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?

Authors:  C C Wu; W L Ho; D C Yeh; C R Huang; T J Liu; F K P'eng
Journal:  Surgery       Date:  1996-07       Impact factor: 3.982

Review 2.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

Authors:  M L Shiffman; C M Hofmann; E B Thompson; A Ferreira-Gonzalez; M J Contos; A Koshy; V A Luketic; A J Sanyal; A S Mills; C T Garrett
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

Review 4.  Aging and the liver.

Authors:  H Popper
Journal:  Prog Liver Dis       Date:  1986

5.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  Hepatic resection for hepatocellular carcinoma.

Authors:  T Tsuzuki; A Sugioka; M Ueda; S Iida; T Kanai; H Yoshii; K Nakayasu
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

Review 7.  Techniques, hemodynamic monitoring, and indications for vascular clamping during liver resections.

Authors:  J Belghiti; J Marty; O Farges
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

Review 8.  Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.

Authors:  W H Caselmann; M Alt
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

9.  Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years.

Authors:  N Nagasue; H Kohno; Y C Chang; H Taniura; A Yamanoi; M Uchida; T Kimoto; Y Takemoto; T Nakamura; H Yukaya
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  92 in total

Review 1.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

3.  Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

Review 4.  Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes.

Authors:  Romaric Loffroy; Sylvain Favelier; Olivier Chevallier; Louis Estivalet; Pierre-Yves Genson; Pierre Pottecher; Sophie Gehin; Denis Krausé; Jean-Pierre Cercueil
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 5.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

6.  Complete versus selective portal triad clamping for minor liver resections.

Authors:  Ingmar Königsrainer; Ruth Ladurner; Wolfgang Steurer; Alfred Königsrainer
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

7.  Parenchymal transection with ultrasonic scalpel in liver resection.

Authors:  O Abbasoglu; I Sayek
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 8.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

9.  Geriatric assessment as a predictor of postoperative complications in elderly patients with hepatocellular carcinoma.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Kosuke Matsui; Hiroya Iida; Kentaro Inoue; Fumio Nagashima; Masanori Kon
Journal:  Langenbecks Arch Surg       Date:  2016-02-23       Impact factor: 3.445

10.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.